Phenotypic changes driven by SMARCA4 inactivation have been previously described in other tumors, including lung adenocarcinoma, where SMARCA4 has a cell-type specificity role in lineage transformation and exhibits divergent functions depending on the cell of origin [15]. Here, SMARCA4 is linked to lung adenocarcinoma.